Amgen 2009 Annual Report Download - page 119
Download and view the complete annual report
Please find page 119 of the 2009 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109 -
110 -
111 -
112 -
113 -
114 -
115 -
116 -
117 -
118 -
119 -
120 -
121 -
122 -
123 -
124 -
125 -
126 -
127 -
128 -
129 -
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
 |
 |
• Registration Statements (Form S-3 No. 333-107639 and Amendment 1 thereto) relating to debt securities,
common stock and associated preferred share repurchase rights, preferred stock, warrants to purchase
debt securities, common stock or preferred stock, securities purchase contracts, securities purchase units
and depositary shares of Amgen Inc. and in the related Prospectuses;
• Registration Statement (Form S-8 No. 333-118254) pertaining to the Amgen Inc. Amended and Restated
1997 Equity Incentive Plan (formerly known as the Tularik Inc. 1997 Equity Incentive Plan, as amended);
• Registration Statement (Form S-3 No. 333-132286) relating to the potential resale of securities acquired
from Amgen Inc. by selling security holders in unregistered private offerings;
• Registration Statement (Form S-8 No. 333-132932) pertaining to the Amgen Inc. Amended and Restated
1996 Incentive Stock Plan (formerly known as Abgenix, Inc. 1996 Incentive Stock Plan, as amended and
restated), the Amgen Inc. Amended and Restated 1999 Incentive Stock Plan (formerly known as Abgenix,
Inc. 1999 Nonstatutory Stock Option Plan, as amended and restated);
• Registration Statement (Form S-8 No. 333-133002) pertaining to the Amgen Inc. Amended and Restated
1999 Incentive Stock Plan (formerly known as Abgenix, Inc. 1999 Nonstatutory Stock Option Plan, as
amended and restated);
• Registration Statement (Form S-8 No. 333-138325) pertaining to the Amgen Inc. Amended and Restated
Assumed Avidia Equity Incentive Plan (formerly known as the Avidia, Inc. Amended and Restated 2003
Equity Incentive Plan);
• Registration Statement (Form S-4 No. 333-147482) relating to the possible exchange of unregistered Se-
nior Floating Notes for registered Senior Floating Notes relating to the Prospectus of Amgen Inc. for the
registration of Senior Floating Rate Notes due 2008, 5.85% Senior Notes due 2017, 6.375% Senior Notes
Due 2037; and
• Registration Statement (Form S-3 No. 333-150290) relating to debt securities, common stock, preferred
stock, warrants to purchase debt securities, common stock, preferred stock or depositary shares, rights to
purchase common stock or preferred stock, securities purchase contracts, securities purchase units and
depositary shares of Amgen Inc. and in the related Prospectuses.
of our report dated March 1, 2010, with respect to the consolidated financial statements of Amgen Inc. in-
corporated herein by reference and our report included in the preceding paragraph with respect to the financial
statement schedule of Amgen Inc. included in this Annual Report (Form 10-K) of Amgen Inc. for the year ended
December 31, 2009.
/s/ Ernst & Young LLP
Los Angeles, California
March 1, 2010
107